Benzinga | Jul 23, 2021 08:33AM EDT

Raymond James Maintains Outperform on Abbott Laboratories, Raises Price Target to $128

Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $116 to $128.